MENU
XLV
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

XLV stock forecast, quote, news & analysis

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
XLV
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for XLV with price predictions
Oct 09, 2026

XLV in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 08, 2026

XLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 41 cases where XLV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 54 cases where XLV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on XLV as a result. In 72 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for XLV just turned positive on October 09, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in 39 of 49 cases over the following month. The odds of a continued upward trend are 80%.

XLV moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 267 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for XLV entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Market Cap

The average market capitalization across the State Street Health Care Select Sector SPDR ETF (XLV) ETF is 107.05B. The market cap for tickers in the group ranges from 9.23B to 1.06T. LLY holds the highest valuation in this group at 1.06T. The lowest valued company is PODD at 9.23B.

High and low price notable news

The average weekly price growth across all stocks in the State Street Health Care Select Sector SPDR ETF (XLV) ETF was 7%. For the same ETF, the average monthly price growth was 48%, and the average quarterly price growth was 294%. MRNA experienced the highest price growth at 18%, while COO experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the State Street Health Care Select Sector SPDR ETF (XLV) ETF was -5%. For the same stocks of the ETF, the average monthly volume growth was 15% and the average quarterly volume growth was 14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 41
Price Growth Rating: 38
SMR Rating: 58
Profit Risk Rating: 74
Seasonality Score: 23 (-100 ... +100)
XLV in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 08, 2026